Chen Zhihui, Wu Jing, Ye Xiangru, Jin Jialin, Zhang Wenhong
Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Department of Infectious Diseases, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China.
Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200030, China.
Antibiotics (Basel). 2025 Jun 27;14(7):652. doi: 10.3390/antibiotics14070652.
infection (CDI) poses substantial clinical and economic challenges worldwide. This study aimed to evaluate the global burden, trends, and inequalities of CDI from 1990 to 2021, with projections extending to 2040.
We conducted a systematic analysis of the Global Burden of Disease Study 2021 data for 204 countries and territories. CDI-related mortality and disability-adjusted life years (DALYs) were analyzed from 1990 to 2021. Joinpoint regression assessed the trends, a decomposition analysis identified the contributing factors, and cross-country inequalities were measured with slope and concentration indices. A log-linear age-period-cohort model projected future burden to 2040.
Global CDI-related deaths increased from 3047 (95% uncertainty interval [UI], 2550-3609) in 1990 to 15,598 (95% UI, 13,418-18,222) in 2021. The age-standardized mortality rate rose from 0.10 to 0.19/100,000 population (average annual percent change [AAPC], 2.26%; 95% confidence interval [CI], 1.77-2.76%), and the age-standardized DALY rate increased from 1.83 to 3.46/100,000 (AAPC, 1.94%; 95% CI, 1.43-2.45%). Epidemiological changes were the primary driver of this burden, contributing 45.46%. Inequalities were intensified, particularly in high sociodemographic index countries, evidenced by increases in the slope index from 2.00 to 4.17 and concentration index from 0.52 to 0.69. The projections suggest that mortality and DALY rates among populations aged ≥80 years will continue to rise through 2040.
The global CDI burden has increased significantly over three decades, disproportionately affecting high sociodemographic index countries. The projected rise in CDI burden among older adults through 2040 underscores the urgent need for targeted interventions and strategic planning.
艰难梭菌感染(CDI)在全球范围内带来了重大的临床和经济挑战。本研究旨在评估1990年至2021年CDI的全球负担、趋势和不平等情况,并预测至2040年。
我们对204个国家和地区的2021年全球疾病负担研究数据进行了系统分析。分析了1990年至2021年与CDI相关的死亡率和伤残调整生命年(DALYs)。Joinpoint回归评估趋势,分解分析确定影响因素,通过斜率和集中指数衡量国家间不平等情况。采用对数线性年龄-时期-队列模型预测至2040年的未来负担。
1990年全球与CDI相关的死亡人数为3047例(95%不确定区间[UI],2550 - 3609),到2021年增至15598例(95% UI,13418 - 18222)。年龄标准化死亡率从0.10/10万人口升至0.19/10万人口(年均变化百分比[AAPC],2.26%;95%置信区间[CI],1.77 - 2.76%),年龄标准化DALY率从1.83/10万升至3.46/10万(AAPC,1.94%;95% CI,1.43 - 2.45%)。流行病学变化是这一负担的主要驱动因素,贡献率为45.46%。不平等加剧,尤其是在社会人口学指数较高的国家,斜率指数从2.00增至4.17,集中指数从0.52增至0.69就证明了这一点。预测表明,到2040年,80岁及以上人群的死亡率和DALY率将持续上升。
在三十年里,全球CDI负担显著增加,对社会人口学指数较高的国家影响尤甚。预计到2040年老年人群中CDI负担的上升凸显了针对性干预措施和战略规划的迫切需求。